Strain-dependent β-adrenergic receptor function influences myocardial responses to isoproterenol stimulation in mice

被引:60
作者
Faulx, MD
Ernsberger, P
Vatner, D
Hoffman, RD
Lewis, W
Strachan, R
Hoit, BD
机构
[1] Univ Hosp Cleveland, Dept Med, Div Cardiol, Cleveland, OH 44106 USA
[2] Case Western Reserve Univ, Dept Med, Div Cardiol, Cleveland, OH 44106 USA
[3] Case Western Reserve Univ, Dept Nutr, Cleveland, OH 44106 USA
[4] Univ Med & Dent New Jersey, New Jersey Med Sch, Cardiovasc Res Inst, Newark, NJ 07103 USA
[5] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Cell Biol & Mol Med, Newark, NJ 07103 USA
[6] Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA
[7] Emory Univ, Dept Pathol, Atlanta, GA 30322 USA
来源
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY | 2005年 / 289卷 / 01期
关键词
echocardiography; myocyte injury;
D O I
10.1152/ajpheart.00636.2004
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Recently, we showed that compared with the A/J inbred mouse strain, C57BL/6J (B6) mice have an athlete's cardiac phenotype. We postulated that strain differences would result in greater left ventricular (LV) hypertrophy in response to isoproterenol in B6 than A/J mice and tested the hypothesis that a differential response could be explained partly by differences in beta-adrenergic receptor (beta-AR) density and/or coupling. A/J and B6 mice were randomized to receive daily isoproterenol (100 mg/kg sc) or isovolumic vehicle for 5 days. Animals were studied using echocardiography, tail-cuff blood pressure, histopathology, beta-AR density and percent high-affinity binding, and basal and stimulated adenylyl cyclase activities. One hundred twenty-eight mice (66 A/J and 62 B6) were studied. Isoproterenol-treated A/J mice demonstrated greater percent increases in echocardiographic LV mass/body weight (97 +/- 11 vs. 20 +/- 10%, P=0.001) and in gravimetric heart mass/body weight versus same-strain controls than B6 mice. Histopathology scores (a composite of myocyte hypertrophy, nuclear changes, fibrosis, and calcification) were greater in isoproterenol-treated A/J vs. B6 mice (2.8 +/- 0.2 vs. 1.9 +/- 0.3, P<0.05), as was quantitation of myocyte damage (22.3 +/- 11.5 vs. 4.3 +/- 3.5%). Interstrain differences in basal beta-AR density, high-affinity binding, and adenylyl cyclase activity were not significant. However, whereas isoproterenol-treated A/J mice showed nonsignificant increases in all beta-AR activity measures, isoproterenol-treated B6 mice had lower beta-AR density (57 +/- 6 vs. 83 +/- 8 fmol/mg, P<0.05), percent high-affinity binding (15 +/- 2 vs. 26 +/- 3%, P<0.005), and GTP + isoproterenol-stimulated adenylyl cyclase activity (10 +/- 1.1 vs. 5.8 +/- 1.5 pmol cAMP center dot mg(-1)center dot min(-1)) compared with controls. High-dose, short-term isoproterenol produces greater macro-and microscopic cardiac hypertrophy and injury in A/J than B6 mice. A/J mice, unlike B6 mice, do not experience beta-AR downregulation or uncoupling in response to isoproterenol. Abnormalities in beta-adrenergic regulation may contribute to strain-related differences in the vulnerability to isoproterenol-induced cardiac changes.
引用
收藏
页码:H30 / H36
页数:7
相关论文
共 28 条
[11]   Effects of chronic beta-adrenergic receptor stimulation in mice [J].
Kudej, RK ;
Iwase, M ;
Uechi, M ;
Vatner, DE ;
Oka, N ;
Ishikawa, Y ;
Shannon, RP ;
Bishop, SP ;
Vatner, SF .
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 1997, 29 (10) :2735-2746
[12]   Isoproterenol-induced cardiac hypertrophy: role of circulatory versus cardiac renin-angiotensin system [J].
Leenen, FHH ;
White, R ;
Yuan, BX .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2001, 281 (06) :H2410-H2416
[13]   PROGNOSTIC IMPLICATIONS OF ECHOCARDIOGRAPHICALLY DETERMINED LEFT-VENTRICULAR MASS IN THE FRAMINGHAM-HEART-STUDY [J].
LEVY, D ;
GARRISON, RJ ;
SAVAGE, DD ;
KANNEL, WB ;
CASTELLI, WP .
NEW ENGLAND JOURNAL OF MEDICINE, 1990, 322 (22) :1561-1566
[14]   Cytoplasmic signaling pathways that regulate cardiac hypertrophy [J].
Molkentin, JD ;
Dorn, GW .
ANNUAL REVIEW OF PHYSIOLOGY, 2001, 63 :391-426
[15]   The Akt-glycogen synthase kinase 3β pathway regulates transcription of atrial natriuretic factor induced by β-adrenergic receptor stimulation in cardiac myocytes [J].
Morisco, C ;
Zebrowski, D ;
Condorelli, G ;
Tsichlis, P ;
Vatner, SF ;
Sadoshima, J .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (19) :14466-14475
[16]   β-Adrenergic cardiac hypertrophy is mediated primarily by the β1-subtype in the rat heart [J].
Morisco, C ;
Zebrowski, DC ;
Vatner, DE ;
Vatner, SF ;
Sadoshima, J .
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2001, 33 (03) :561-573
[17]   ROLE OF CARDIAC ANGIOTENSIN-II IN ISOPROTERENOL-INDUCED LEFT-VENTRICULAR HYPERTROPHY [J].
NAGANO, M ;
HIGAKI, J ;
NAKAMURA, F ;
HIGASHIMORI, K ;
NAGANO, N ;
MIKAMI, H ;
OGIHARA, T .
HYPERTENSION, 1992, 19 (06) :708-712
[18]   HIGHLY SENSITIVE ADENYLATE CYCLASE ASSAY [J].
SALOMON, Y ;
LONDOS, C ;
RODBELL, M .
ANALYTICAL BIOCHEMISTRY, 1974, 58 (02) :541-548
[19]  
Scheuer J, 1999, AM J CARDIOL, V83, p70H
[20]   Central role for ornithine decarboxylase in β-adrenoceptor mediated hypertrophy [J].
Schlüter, KD ;
Frischkopf, K ;
Flesch, M ;
Rosenkranz, S ;
Taimor, G ;
Piper, HM .
CARDIOVASCULAR RESEARCH, 2000, 45 (02) :410-417